Publication #7494
Reference
CEM_CMO(2021)022
Name
COVID therapeutic alert – interim clinical commissioning policy on the use of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19
Categories
Scottish Government
CMO Letters
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
COVID-19
CORONAVIRUS
TREATMENTS
DRUGS
IMMUNISATION
PATIENTS
HEALTHCARE PROFESSIONALS
Description
Please see below CMO letter and interim clinical commissioning policy regarding the use of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 for dissemination to relevant healthcare professionals.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2021-12-16 00:00:00
Click to go back to homepage